Seminars in Nuclear Medicine
Volume 38, Issue 4 , Pages 240-250 , July 2008

Advances in Evaluation of Primary Brain Tumors

  • Wei Chen, MD, PhD

      Affiliations

    • Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.
    • Department of Radiology, Kaiser Permanente Woodland Hills Medical Center, Woodland Hills, CA.
    • Corresponding Author InformationAddress reprint requests to Wei Chen, MD, PhD, Nuclear Medicine Clinic, CHS AR-144, UCLA School of Medicine, MC694215, Los Angeles, CA 90095-6942.
    • ,
  • Daniel H.S. Silverman, MD, PhD

      Affiliations

    • Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was supported by grants P50 CA086306 from the National Institutes of Health–National Cancer Institute and U.S. Department of Energy contract DE-FC03-87-ER60615.

PII: S0001-2998(08)00028-7

doi: 10.1053/j.semnuclmed.2008.02.005

Seminars in Nuclear Medicine
Volume 38, Issue 4 , Pages 240-250 , July 2008

Article Tools

* Image Usage & Resolution